Phase II Trial of Exemestane in Previously Treated Post-Menopausal Women With Advanced Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2018
At a glance
- Drugs Exemestane (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 30 May 2018 Planned number of patients changed from 56 to 29.
- 04 Jan 2018 Status changed from recruiting to suspended.
- 15 Aug 2016 Status changed from not yet recruiting to recruiting.